IC
LLY icon

Ikarian Capital’s Eli Lilly LLY Stock Holding History

Ikarian Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150,000
Closed -$124M – 169
2025
Q1 		$124M Buy
+150,000
New +$125M 15.27% 2
2024
Q1 		– Sell
-70,000
Closed -$40.8M – 163
2023
Q4 		$40.8M Buy
+70,000
New +$40.9M 3.82% 4

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ikarian Capital's LLY Position: Q1 2026 in Review

Ikarian Capital reduced its Eli Lilly (LLY) stake by 53% in Q1 2026, selling an estimated $7.37M and leaving 6,547 shares worth $6.02M. The position accounts for 0.49% of the portfolio, ranked #52.

Ikarian Capital first reported a position in LLY in Q1 2021 and has held it in 5 quarters since. The position peaked at $23.4M in Q1 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ikarian Capital held 6,547 shares of Eli Lilly worth $6.02M as of Q1 2026.
  • Ikarian Capital sold 7,268 Eli Lilly shares in Q1 2026, an estimated $7.37M.
  • Eli Lilly made up 0.49% of Ikarian Capital's portfolio in Q1 2026, its #52 holding.
  • Ikarian Capital first reported a position in Eli Lilly in Q1 2021 and has held it in 5 quarters since.
  • Ikarian Capital's Eli Lilly position peaked at $23.4M in Q1 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.